PSGL-1/CD162 Antibodies
We offer PSGL-1/CD162 Antibodies for use in common research applications: Adhesion Blockade, Flow (Cell Surface), Flow Cytometry, Immunohistochemistry-Paraffin, Immunoprecipitation, Western Blot. Each PSGL-1/CD162 Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our PSGL-1/CD162 Antibodies can be used in a variety of model species: Human, Primate. Use the list below to choose the PSGL-1/CD162 Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our PSGL-1/CD162 polyclonal antibodies and browse our PSGL-1/CD162 monoclonal antibody catalog.
Alternate Names for PSGL-1/CD162 Antibodies
anti-PSGL-1/CD162 antibody, anti-SELPLG antibody, anti-CD162 antibody, anti-CD162 antigen antibody, anti-P-selectin glycoprotein ligand 1 antibody, anti-PSGL-1cutaneous lymphocyte-associated associated antigen antibody, anti-PSGL1 antibody, anti-selectin P ligandCLA antibody
27 Results for "psgl-1-cd162" in Primary Antibodies
![Western Blot: PSGL-1/CD162 Antibody (HECA-452) [NB100-78039] - Cutaneous Lymphocyte Antigen (CLA) Antibody (HECA-452) [NB100-78039] - Analysis of human tonsil (1), human spleen (2), and human lymph node (3) tissue using CD162 antibody at a concentration of 2 ug/ml.](http://images.novusbio.com/fullsize/Cutaneous-Lymphocyte-Antigen-CLA-Antibody-HECA-452-Western-Blot-NB100-78039-img0006.jpg "Western Blot: PSGL-1/CD162 Antibody (HECA-452) [NB100-78039] - Cutaneous Lymphocyte Antigen (CLA) Antibody (HECA-452) [NB100-78039] - Analysis of human tonsil (1), human spleen (2), and human lymph node (3) tissue using CD162 antibody at a concentration of 2 ug/ml.")
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (HECA-452) [NB100-78039] - Human tonsil tissue stained with PSGL-1/CD162 Antibody (HECA-452) at 5ug/mL, and Leica Refine DAB kit. IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-HECA-452-Immunohistochemistry-Paraffin-NB100-78039-img0014.jpg)
![Flow (Cell Surface): PSGL-1/CD162 Antibody (HECA-452) [NB100-78039] - Cutaneous Lymphocyte Antigen (CLA) Antibody (HECA-452) [NB100-78039] - A cell surface stain was performed on CD3+ hPBMCs with Cutaneous Lymphocyte Antigen (CLA) antibody (HECA-452) NB100-78039 and a matched isotype control NBP2-31379. Cells were incubated in an antibody dilution of 1 ug/mL for 20 minutes at room temperature, followed by mouse F(ab)2 IgG (H+L) APC-conjugated secondary antibody [F0101B, R&D Systems]. A co-stain was performed using CD3 antibody NBP2-25186APC.](http://images.novusbio.com/fullsize/Cutaneous-Lymphocyte-Antigen-CLA-Antibody-HECA-452-Flow-Cell-Surface-NB100-78039-img0008.jpg)
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (HECA-452) [NB100-78039] - Cutaneous Lymphocyte Antigen (CLA) Antibody (HECA-452) [NB100-78039] - IHC analysis of formalin-fixed paraffin-embedded tissue section of human breast adenocarcinoma using CLA antibody (clone HECA-452) at 5 ug/ml concentration. The antibody generated a membrane-cytoplasmic staining in the cancerous cells of breast adenocarcinoma. Note:- Besides lymphocytes, CLA has been shown to be present on cells of normal endometrium as well as breast cancer tissues (PMID 19625313 and 22970241).](http://images.novusbio.com/fullsize/Cutaneous-Lymphocyte-Antigen-CLA-Antibody-HECA-452-Immunohistochemistry-Paraffin-NB100-78039-img0004.jpg)
![Flow Cytometry: PSGL-1/CD162 Antibody (HECA-452) [NB100-78039] - Cutaneous Lymphocyte Antigen (CLA) Antibody (HECA-452) [NB100-78039] - Human peripheral blood lymphocytes stained with purified HECA-452, followed by anti-mouse IgG FITC](http://images.novusbio.com/fullsize/Cutaneous-Lymphocyte-Antigen-CLA-Antibody-HECA-452-Flow-Cytometry-NB100-78039-img0005.jpg)
![Flow (Cell Surface): PSGL-1/CD162 Antibody (HECA-452) [NB100-78039] - Cutaneous Lymphocyte Antigen (CLA) Antibody (HECA-452) [NB100-78039] - A cell surface stain was performed on CD14+ hPBMCs with Cutaneous Lymphocyte Antigen (CLA) antibody (HECA-452) NB100-78039 and a matched isotype control NBP2-31379. Cells were incubated in an antibody dilution of 1 ug/mL for 20 minutes at room temperature, followed by rat-Dylight 488 conjugated secondary antibody. A co-stain was performed using CD14 antibody NB100-77758AF488.](http://images.novusbio.com/fullsize/Cutaneous-Lymphocyte-Antigen-CLA-Antibody-HECA-452-Flow-Cell-Surface-NB100-78039-img0007.jpg)
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (031) [NBP2-90247] - Staining of human SELPLG in human tonsil with rabbit monoclonal antibody (1:200).](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-031-Immunohistochemistry-Paraffin-NBP2-90247-img0003.jpg "Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (031) [NBP2-90247] - Staining of human SELPLG in human tonsil with rabbit monoclonal antibody (1:200).")
![Flow Cytometry: PSGL-1/CD162 Antibody (031) [NBP2-90247] - Analysis of Human SELPLG(CD162) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SELPLG(CD162), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-031-Flow-Cytometry-NBP2-90247-img0002.jpg)
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (031) [NBP2-90247] - Staining of human SELPLG in human spleen with rabbit monoclonal antibody (1:200).](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-031-Immunohistochemistry-Paraffin-NBP2-90247-img0001.jpg)
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (PSGL1/1601) [NBP2-53344] - Formalin-fixed, paraffin-embedded human Tonsil stained with PSGL-1/CD162 Antibody (PSGL1/1601).](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-PSGL1-1601-Immunohistochemistry-Paraffin-NBP2-53344-img0003.jpg "Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (PSGL1/1601) [NBP2-53344] - Formalin-fixed, paraffin-embedded human Tonsil stained with PSGL-1/CD162 Antibody (PSGL1/1601).")
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (PSGL1/1601) [NBP2-53344] - Formalin-fixed, paraffin-embedded human Spleen stained withCD162 Monoclonal Antibody (PSGL1/1601).](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-PSGL1-1601-Immunohistochemistry-Paraffin-NBP2-53344-img0001.jpg)
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody (PSGL1/1601) [NBP2-53344] - Formalin-fixed, paraffin-embedded human Tonsil stained withCD162 Monoclonal Antibody (PSGL1/1601).](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-PSGL1-1601-Immunohistochemistry-Paraffin-NBP2-53344-img0002.jpg)
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody [NBP3-16974] - Analysis in human lymph node and skeletal muscle tissues using Anti-SELPLG antibody. Corresponding SELPLG RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-Immunohistochemistry-Paraffin-NBP3-16974-img0004.jpg "Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody [NBP3-16974] - Analysis in human lymph node and skeletal muscle tissues using Anti-SELPLG antibody. Corresponding SELPLG RNA-seq data are presented for the same tissues.")
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody [NBP3-16974] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-Immunohistochemistry-Paraffin-NBP3-16974-img0001.jpg)
![Immunohistochemistry-Paraffin: PSGL-1/CD162 Antibody [NBP3-16974] - Staining of human skeletal muscle shows low expression as expected.](http://images.novusbio.com/fullsize/PSGL-1-CD162-Antibody-Immunohistochemistry-Paraffin-NBP3-16974-img0002.jpg)
